4552 JCR Pharmaceuticals
- 680
- -12-1.73%
JCR Pharmaceuticals News
JCR Pharmaceuticals: Earnings reports for Q1 of March 2025 will be announced in a conference call.
JCR Pharmaceuticals: 2025 March 1st quarter financial report announcement [Japan standard] (Consolidated)
JCR Pharmaceuticals: Extraordinary Report
JCR Pharmaceuticals: Interim report
JCR Pharmaceuticals: (Correction- Numerical Data Correction) Partial correction of the Financial results briefing[Japan Standard] (Consolidated) for the fiscal year ending March 2024.
JCR Pharmaceuticals: Confirmation letter
JCR Pharmaceuticals: Securities report - 49th period (April 1, 2023 - March 31, 2024)
JCR Pharmaceuticals: Presentation materials for the financial results briefing for the fiscal year ending March 31, 2024
JCR Pharmaceuticals: (Correction) Partial Corrections to the “Financial Results Report Supplementary Material for the Fiscal Year Ending 2024/3”
JCR Pharmaceuticals: Supplementary material for the financial results report for the fiscal year ending 2024/3
JCR Pharmaceuticals: Notice Concerning Dividends from Surplus Funds (Year-end Dividend)
JCR Pharmaceuticals: Summary of Financial Results for the Fiscal Year Ending March 31, 2024 [Japanese GAAP] (Consolidated)
JCR Pharma: Confirmation
JCR Pharma: Quarterly Report - 49th Quarter 3rd Quarter (2023/10/01 to 2023/12/31)
JCR Pharmaceuticals: Summary of Financial Results for the 3rd Quarter of the Fiscal Year Ending March 31, 2024 [Japanese GAAP] (Consolidated)
JCR Pharmaceuticals: Supplementary material for the 3rd quarter financial results summary for the fiscal year ending March 31, 2024
JCR Pharmaceuticals: Correction Confirmation Form
JCR Pharmaceuticals: Corrected Financial Report - 48th Term (2022/04/01－2023/03/31)
JCR Pharmaceuticals: Confirmation letter
JCR Pharmaceuticals: Quarterly Report - 49th Second Quarter (2023/07/01 - 2023/09/30)
Analysis
Price Target
No Data
No Data